Hepatitis Panel Testing

A hepatitis panel measures selected markers related to hepatitis A, B, and C rather than providing one single hepatitis result. The Hepatitis Panel Acute, w/ Ref Confirmation includes hepatitis A IgM, hepatitis B surface antigen, hepatitis B core IgM, and hepatitis C antibody. That combination is useful when evaluating a recent illness question across multiple viral hepatitis types.

Hepatitis A IgM is used to assess a recent immune response, whereas hepatitis A total antibody shows antibody status without distinguishing recent response from prior exposure or immunity. A total-antibody result therefore answers a different question than an IgM result. Symptoms, timing, vaccination history, and professional interpretation help place either result in meaning.

Hepatitis B surface antigen, or HBsAg, is an infection-related screening marker, while hepatitis B surface antibody is an antibody measurement relevant to immunity status. The Hepatitis B Profile measures both, along with hepatitis B core IgM. Reading those three results together helps separate the practical questions of possible current infection-related findings and antibody evidence.

Hepatitis B core IgM helps assess a recent immune response to hepatitis B. Alongside HBsAg and quantitative hepatitis B surface antibody, it adds timing-related information that a surface antigen or surface antibody result alone does not provide. It does not independently diagnose infection, and results warrant professional review when they are positive or symptoms are present.

Hepatitis C antibody is used to screen for antibody evidence of exposure to hepatitis C. The Hepatitis C Antibody with Reflex begins with that antibody measurement and includes a reflex pathway in its named test design. An antibody result does not by itself establish current infection, so follow-up laboratory findings and professional interpretation are important.

The Hepatitis Panel Acute, w/ Ref Confirmation screens across hepatitis A, B, and C using hepatitis A IgM, HBsAg, hepatitis B core IgM, and hepatitis C antibody. The Hepatitis B Profile focuses on hepatitis B and adds quantitative hepatitis B surface antibody. The first fits a broad recent-illness question; the second addresses hepatitis B infection-related and immunity-related markers.

ALT and AST are enzymes that can rise with liver-cell injury, while total, direct, and indirect bilirubin describe bilirubin levels and distribution. The Hepatitis B Disease Monitoring Profile combines these results with hepatitis B markers, albumin, globulin, and total protein. ALT and AST are not specific to hepatitis and can rise after strenuous exercise or with muscle injury.

No, a hepatitis panel provides laboratory findings that support screening or monitoring but does not diagnose hepatitis by itself. Marker patterns, symptom timing, exposure history, and related laboratory results all affect interpretation. Positive findings, significant symptoms, jaundice, or abnormal bilirubin and enzyme results should be reviewed promptly with a qualified healthcare professional.

For hepatitis B immunity questions, the Hepatitis B Profile measures quantitative hepatitis B surface antibody together with HBsAg and hepatitis B core IgM. For hepatitis A, total antibody addresses overall antibody status, while hepatitis A IgM addresses a recent immune response. Those are distinct measurements, so selecting one depends on whether the question concerns hepatitis A or B and recent response versus antibody status.

You'll receive it via email within 60 seconds of your order unless it requires additional processing (only very complex orders do).

Many general wellness test results are typically available online within 2-3 business days. However, some tests will require additional processing time. You will immediately receive an email & SMS notification when your results are available.

We do not share your results with your physician, insurance company, or any other third party.